8-K 1 form8k063007.htm FORM 8-K 06/30/07 form8k063007.htm
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):                                                            July 19, 2007
 
MERIDIAN BIOSCIENCE, INC.
(Exact name of registrant as specified in its charter)

Ohio
0-14902
31-0888197
(State or other jurisdiction of incorporation)
(Commission File Number)
 
(IRS Employer Identification No. )

3471 River Hills Drive, Cincinnati, Ohio
 
45244
(Address of principal executive offices)
 
(Zip Code)

 
Registrant’s telephone number, including area code (513) 271-3700
 



Item 2.02.                                Results of Operations and Financial Condition.
 
On July 19, 2007, the Registrant issued a press release announcing its financial results for the fiscal quarter and nine months ended June 30, 2007.  A copy of the press release is furnished as Exhibit 99 to this report and is incorporated herein by reference.
 
Item 9.01.                                Financial Statements and Exhibits.
 
(d)           Exhibits
 
 
99
Press Release dated July 19, 2007
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
  MERIDIAN BIOSCIENCE, INC.  
       
Date:  July 23, 2007
By:
/s/   Melissa Lueke  
    Melissa Lueke  
   
Vice President and Chief Financial Officer
(Principal Accounting Officer)